Arnedos, M <br/><br/>
Modulation of Rb phosphorylation and antiproliferative response to palbociclib: the preoperative-palbociclib (POP) randomized clinical trial.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  08 2018 
 - 1755-1762 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1569-8041 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdy202  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Aged<br/>Antineoplastic Agents--pharmacology<br/>Biopsy<br/>Breast--pathology<br/>Breast Neoplasms--pathology<br/>Cell Proliferation--drug effects<br/>Cyclin-Dependent Kinase 4--antagonists & inhibitors<br/>Cyclin-Dependent Kinase 6--antagonists & inhibitors<br/>Drug Resistance, Neoplasm<br/>Female<br/>Humans<br/>Ki-67 Antigen--analysis<br/>Middle Aged<br/>Neoadjuvant Therapy--methods<br/>Phosphorylation--drug effects<br/>Piperazines--pharmacology<br/>Pyridines--pharmacology<br/>Receptor, ErbB-2--metabolism<br/>Receptors, Estrogen--metabolism<br/>Receptors, Progesterone--metabolism<br/>Retinoblastoma Binding Proteins--metabolism<br/>Treatment Outcome<br/>Ubiquitin-Protein Ligases--metabolism